These cytokines can lead to decreased insulin sensitivity of insulin target cells (adipocytes, hepatocytes, and muscle cells) through paracrine signaling or infiltration into the systemic circulation, promoting the progression of insulin resistance and systemic hyperglycemia [107]. The gene discussed is INS; the disease is Hyperglycemia.